White House Press Secretary Says There Is Nothing In The Constitution That Prevents Medicare From Negotiating Lower Drug Prices
Portfolio Pulse from Benzinga Newsdesk
White House Press Secretary stated that there is nothing in the Constitution preventing Medicare from negotiating lower drug prices, potentially impacting pharmaceutical companies and healthcare providers.
June 06, 2023 | 5:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cigna may be impacted by potential Medicare negotiations for lower drug prices, affecting the company's revenue.
As a healthcare provider, Cigna may see a decrease in revenue if Medicare negotiates lower drug prices, as it could lead to lower margins on pharmaceutical sales.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
NEGATIVE IMPACT
Humana may be affected by potential Medicare negotiations for lower drug prices, impacting the company's revenue.
As a healthcare provider, Humana may see a decrease in revenue if Medicare negotiates lower drug prices, as it could lead to lower margins on pharmaceutical sales.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
NEGATIVE IMPACT
iShares U.S. Healthcare ETF (IYH) may be impacted by potential Medicare negotiations for lower drug prices, affecting the ETF's holdings.
As an ETF with holdings in healthcare providers and pharmaceutical companies, IYH may see a decrease in value if Medicare negotiates lower drug prices, impacting its holdings' revenues.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
NEGATIVE IMPACT
UnitedHealth Group may be impacted by potential Medicare negotiations for lower drug prices, affecting the company's revenue.
As a healthcare provider, UnitedHealth Group may see a decrease in revenue if Medicare negotiates lower drug prices, as it could lead to lower margins on pharmaceutical sales.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75